Table 1.
Associations between MCT1 expression and clinicopathological variables in 560 surgically resected patients with gastric adenocarcinoma.
| Variable | MCT1 | Total | p-Value | ||
|---|---|---|---|---|---|
| Low | High | ||||
| Year of surgery | |||||
| ≥2000 | 136 (44.6%) | 111 (43.5%) | 247/560 | 0.864 | |
| <2000 | 169 (55.4%) | 144 (56.5%) | 313/560 | ||
| Age | |||||
| <69 | 163 (53.4%) | 120 (47.1%) | 283/560 | 0.149 | |
| ≥69 | 142 (46.6%) | 135 (52.1%) | 277/560 | ||
| Sex | |||||
| Male | 191 (62.6%) | 150 (58.8%) | 341/560 | 0.385 | |
| Female | 114 (37.4%) | 105 (41.2%) | 219/560 | ||
| T | |||||
| T1 + 2 | 103 (33.8%) | 63 (24.7%) | 166/560 | 0.020 | |
| T3 + 4 | 202 (66.2%) | 192 (75.3%) | 394/560 | ||
| Lymph nodes | |||||
| negative | 163 (53.4%) | 132 (51.8%) | 295/560 | 0.734 | |
| positive | 142 (46.6%) | 123 (48.2%) | 265/560 | ||
| Organ metastases | |||||
| negative | 292 (95.7%) | 235 (92.2%) | 527/560 | 0.104 | |
| positive | 13 (4.3%) | 20 (7.8%) | 33/560 | ||
| Stage | |||||
| I + II | 186 (61.0%) | 155 (60.8%) | 341/560 | 0.515 | |
| III + IV | 119 (39.0%) | 100 (39.2%) | 219/560 | ||
| Histological grade in intestinal type | |||||
| I | 99 (62.3%) | 79 (62.7%) | 178/285 | 1.000 | |
| II + III | 60 (37.7%) | 47 (37.3%) | 107/285 | ||
| Lauren | |||||
| Intestinal | 159 (52.1%) | 126 (49.4%) | 285/560 | 0.790 | |
| Diffuse | 137 (44.9%) | 120 (47.1%) | 257/560 | ||
| Other * | 9 (3.0%) | 9 (3.5%) | 18/560 | ||
| Perioperative chemotherapy | |||||
| Yes | 10 (3.3%) | 12 (4.7%) | 538/560 | 0.513 | |
| No | 295 (96.7%) | 243 (94.3%) | 22/560 | ||
| Radicality of resection | |||||
| R0 | 234 (76.7%) | 183 (71.8%) | 417/560 | 0.206 | |
| R1 or R2 | 71 (23.3%) | 72 (28.2%) | 143/560 | ||
Other *: mixed, no classified; Statistically significant values are bolded.